Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acute childhood leukemia].

T Fujimoto

    [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
    |August 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Childhood acute leukemia survival rates have improved due to integrated research efforts. Advances in drug development and combination chemotherapy are key to treating acute lymphoblastic leukemia (ALL) and acute non-lymphoblastic leukemia (ANLL).

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Localization of inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae.

    The Journal of cell biology·1992
    Same author

    Structural transformation of lignan compounds in rat gastrointestinal tract.

    Planta medica·1992
    Same author

    Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging.

    Acta psychiatrica Scandinavica·1992
    Same author

    Short- and mid-term follow-up results after percutaneous transvenous mitral commissurotomy.

    Japanese heart journal·1992
    Same author

    A method to obtain avian germ-line chimaeras using isolated primordial germ cells.

    Journal of reproduction and fertility·1992
    Same author

    [A case of interstitial pneumonitis associated with polymyositis complicated by renal cell carcinoma].

    Nihon Kyobu Shikkan Gakkai zasshi·1992
    Same journal

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Recent advances in pathogenesis, diagnosis, and therapeutic strategies for POEMS syndrome].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Recent advances in management of systemic AL amyloidosis].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Treatment strategies for relapsed or refractory multiple myeloma: proposals for optimal treatment sequencing].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    See all related articles

    Area of Science:

    • Pediatric Oncology
    • Hematology
    • Clinical Pharmacology

    Context:

    • Childhood acute leukemia remains a significant health concern globally.
    • Significant advancements in treatment protocols have improved patient outcomes.
    • The Children's Cancer and Leukemia Study Group of Japan has contributed substantially to this progress.

    Purpose:

    • To review recent treatment results for childhood acute leukemia in Japan.
    • To discuss current challenges and future directions in pediatric leukemia therapy.
    • To highlight the impact of integrated scientific efforts on survival rates.

    Summary:

    • Event-free survival for childhood acute lymphoblastic leukemia (ALL) has reached 60-65%, and for acute non-lymphoblastic leukemia (ANLL), it is 40-60%.

    Related Experiment Videos

  • Progress is attributed to coordinated efforts in drug development, preclinical modeling, clinical trial design, and response criteria.
  • Key therapeutic strategies studied include combination chemotherapy, dose optimization, and agent sequencing.

    • Impact:

    • Improved survival rates for childhood acute leukemia patients.
    • Enhanced understanding of effective treatment modalities, particularly combination chemotherapy.
    • Established a foundation for future research and therapeutic innovations in pediatric hematologic malignancies.